Anne E Cust
Overview
Explore the profile of Anne E Cust including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
190
Citations
3140
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Lo S, Williams G, Cust A, Varey A, Md S, Chng S, et al.
J Natl Cancer Inst
. 2024 Sep;
117(1):152-156.
PMID: 39245462
The prognosis of a patient with a primary cutaneous melanoma is known to be related to the Breslow thickness of their tumor. This study sought to determine long-term (30-year) survival...
12.
Martin L, Guitera P, Long G, Scolyer R, Cust A
Med J Aust
. 2024 Sep;
221(8):407-409.
PMID: 39239780
No abstract available.
13.
Cust A, Scolyer Ao R, Long Ao G
Med J Aust
. 2024 Sep;
221(5):246-247.
PMID: 39217599
No abstract available.
14.
Martin A, Cust A, Lo S, Morton R, Kasparian N, Collgros H, et al.
J Eur Acad Dermatol Venereol
. 2024 Aug;
38(12):2316-2319.
PMID: 39206969
No abstract available.
15.
Zheng L, Smit A, Cust A, Janda M
J Pers Med
. 2024 Aug;
14(8).
PMID: 39202054
This scoping review aims to systematically gather evidence from personalized cancer-screening studies across various cancers, summarize key components and outcomes, and provide implications for a future personalized melanoma-screening strategy. Peer-reviewed...
16.
Perera M, Smit A, Smith A, Gallo B, Tan I, Espinoza D, et al.
Int J Cancer
. 2024 Aug;
155(11):2058-2067.
PMID: 39177494
Population-wide skin cancer screening is not currently recommended in most countries. Instead, most clinical guidelines incorporate risk-based recommendations for skin checks, despite limited evidence around implementation and adherence to recommendations...
17.
Spanos S, Singh N, Laginha B, Arnolda G, Smith A, Wilkinson D, et al.
BMJ Open
. 2024 Jul;
14(7):e080670.
PMID: 38991668
Objectives: This study explored potential quality measures to improve skin cancer management in primary care settings, and the barriers and facilitators associated with their implementation. Design: Semistructured interviews and qualitative...
18.
Salisbury A, Ciardi J, Norman R, Smit A, Cust A, Low C, et al.
Appl Health Econ Health Policy
. 2024 Jun;
PMID: 38916649
Purpose: Genetic and genomic testing can provide valuable information on individuals' risk of chronic diseases, presenting an opportunity for risk-tailored disease screening to improve early detection and health outcomes. The...
19.
Smith J, Espinoza D, Smit A, Gallo B, Smith A, Lo S, et al.
Australas J Dermatol
. 2024 Jun;
65(6):e156-e163.
PMID: 38845454
Objective: We investigated the association between sun protection behaviours and demographic and melanoma risk characteristics of patients attending Australian melanoma specialist clinics. This may assist in targeting and tailoring melanoma...
20.
Winder A, Boyer Z, Chng S, Stretch J, Saw R, Shannon K, et al.
Ann Surg Oncol
. 2024 May;
31(8):5331-5339.
PMID: 38802717
Background: Predicting which patients with American Joint Committee on Cancer (AJCC) T1-T2 melanomas will have a positive sentinel lymph node (SLN) is challenging. Melanoma Institute Australia (MIA) developed an internationally...